Recombinant adenovirus expressing mouse IL-12p40 gene
|
Other clones in our bank
External Database Mouse IL-12 p40 Reference sequence |
Remarks, protocol and/or map (gif) | RDB01417.gif |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(J. Clin. Invest., 102, 1807-1814 (1988).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) and an acknowledgment to Dr. Jun-ich Miyazaki of the Osaka University are requested. |
---|---|
Ordering | Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] |
提供条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(J. Clin. Invest., 102, 1807-1814 (1988).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 付加的提供条件: CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用し、大阪大学 宮崎純一博士への謝辞の表明を必要とする。 |
---|---|
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] 遺伝子組換え生物の受入れ確認書 [Word] |
備考 | 【追加提供依頼書】受入れ確認書(書式J) 組換え体提供にかかる書式が必要です。 |
Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
---|---|---|---|---|
RDB01417 | AxCAmIL12p40 | Under QC test. Please contact us. | Virus, lysate of infected cell culture |
Materials & Methods section:
The AxCAmIL12p40 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01417). |
Reference section:
Yasuda, H., Nagata, M., Arisawa, K., Yoshida, R., Fujihira, K., Okamoto, N., Moriyama, H., Miki, M., Saito, I., Hamada, H., Yokono, K., Kasuga, M., Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J. Clin. Invest., 102, 1807-1814 (1988). PMID 9819366. |
Further references such as user reports and related articles (go to bottom)
Featured content
Original, user report and related articles
original | Yasuda, H., Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J. Clin. Invest., 102, 1807-1814 (1988). PMID 9819366. |
---|---|
user_report | Ojima T., The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Int. J. Oncol., 28, 947-953 (2006). PMID 16525645. |
user_report | Furumoto K., Interleukin-12-gene transduction makes DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal dissemination model. Immunol. Lett., 83, 13-20 (2002). PMID 12057850. |
user_report | Furumoto K., Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses. Int. J. Cancer., 87, 665-672 (2000). PMID 10925360. |
2023.05.02
GNP_filter3_RDBDEP_html_230501.pl